Ljubljana, Slovenia

Tadeja Kuzman

This inventor holds 1 USPTO granted patent. Top assignee: Lek, Tovarna Farmacevtskih in Kemicnih Izdelkov, D.d.. Active years: 2002.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tadeja Kuzman: Innovator in Pharmaceutical Chemistry

Introduction

Tadeja Kuzman is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on carbapenems. His expertise and dedication to research have led to the development of valuable patents that enhance the pharmaceutical industry.

Latest Patents

Tadeja Kuzman holds a patent for "Ethylidene derivatives of tricyclic carbapenems." This invention represents a significant advancement in the development of antibiotic compounds, showcasing his ability to innovate within a critical area of medicine. The patent reflects his commitment to improving healthcare through scientific research.

Career Highlights

Kuzman is currently employed at Lek, Tovarna Farmacevtskih in Kemicnih Izdelkov, D.d., a leading pharmaceutical company in Slovenia. His role at Lek allows him to apply his knowledge and skills in a practical setting, contributing to the development of new pharmaceutical products. His work has been instrumental in advancing the company's research initiatives.

Collaborations

Tadeja Kuzman has collaborated with esteemed colleagues such as Anton Copar and Tomaz Solmajer. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the quality of their research.

Conclusion

Tadeja Kuzman is a prominent figure in the field of pharmaceutical chemistry, with a focus on developing innovative solutions for antibiotic treatments. His contributions through patents and collaborations highlight his commitment to advancing healthcare. His work continues to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…